Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
2,5-Dimethoxy-4-methylphenylcyclopropylamine
Другие языки:

2,5-Dimethoxy-4-methylphenylcyclopropylamine

Подписчиков: 0, рейтинг: 0
2,5-Dimethoxy-4-methylphenylcyclopropylamine
DMCPA.svg
DMCPA-3d-sticks.png
Names
Preferred IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropan-1-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
UNII
  • InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 checkY
    Key: HYVPPECPQRBJEQ-UHFFFAOYSA-N checkY
  • InChI=1/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3
    Key: HYVPPECPQRBJEQ-UHFFFAOYAN
  • O(c1c(cc(OC)c(c1)C2CC2N)C)C
Properties
C12H17NO2
Molar mass 207.273 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also


Новое сообщение